Technical Analysis for 0RV2 - BioArctic AB Series B
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 197.80 | 0.00% | 0.00 |
Earnings due: May 22
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| 200 DMA Resistance | Bearish | 0.00% | |
| 50 DMA Resistance | Bearish | 0.00% | |
| Shooting Star Candlestick | Bearish | 0.00% | |
| Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
| Boomer Sell Setup | Bearish Swing Setup | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% |
Get a Trading Assistant
BioArctic AB Series B Description
BioArctic AB (publ) develops biological drugs for patients with neurodegenerative disorders in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. It also develops ABBV-0805, for treating Parkinson's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain, as well as focuses on developing ND3014 antibodies for treating neurodegenerative disorders. Further, it develops BAN1503, AD-BT2802, AD-BT2803, AD1502, AD1503, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814 andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, BAN0805, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.
Classification
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 391.0 |
| 52 Week Low | 183.05 |
| Average Volume | 4,206 |
| 200-Day Moving Average | 272.81 |
| 50-Day Moving Average | 235.50 |
| 20-Day Moving Average | 206.98 |
| 10-Day Moving Average | 197.62 |
| Average True Range | 81.77 |
| RSI (14) | 38.65 |
| ADX | 56.64 |
| +DI | 0.54 |
| -DI | 4.06 |
| Chandelier Exit (Long, 3 ATRs) | 50.29 |
| Chandelier Exit (Short, 3 ATRs) | 428.35 |
| Upper Bollinger Bands | 231.89 |
| Lower Bollinger Band | 182.06 |
| Percent B (%b) | 0.32 |
| BandWidth | 24.07 |
| MACD Line | -11.06 |
| MACD Signal Line | -11.30 |
| MACD Histogram | 0.2348 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 344.49 | ||||
| Resistance 3 (R3) | 360.79 | 328.19 | 320.04 | ||
| Resistance 2 (R2) | 328.19 | 290.84 | 320.04 | 311.89 | |
| Resistance 1 (R1) | 263.00 | 267.76 | 246.70 | 246.70 | 303.74 |
| Pivot Point | 230.40 | 230.40 | 222.25 | 222.25 | 230.40 |
| Support 1 (S1) | 165.20 | 193.04 | 148.90 | 148.90 | 91.86 |
| Support 2 (S2) | 132.60 | 169.96 | 124.45 | 83.71 | |
| Support 3 (S3) | 67.41 | 132.60 | 75.56 | ||
| Support 4 (S4) | 51.11 |
